BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34168983)

  • 1. Profiling of 520 Candidate Genes in 50 Surgically Treated Chinese Small Cell Lung Cancer Patients.
    Yuan T; Wang X; Sun S; Cao Z; Feng X; Gao Y
    Front Oncol; 2021; 11():644434. PubMed ID: 34168983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive genomic profiling of small cell lung cancer in Chinese patients and the implications for therapeutic potential.
    Hu J; Wang Y; Zhang Y; Yu Y; Chen H; Liu K; Yao M; Wang K; Gu W; Shou T
    Cancer Med; 2019 Aug; 8(9):4338-4347. PubMed ID: 31199602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic features of Chinese small cell lung cancer.
    Liu J; Zhao Z; Wei S; Li B; Zhao Z
    BMC Med Genomics; 2022 May; 15(1):117. PubMed ID: 35596192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic based analyses reveal unique mutational profiling and identify prognostic biomarker for overall survival in Chinese small-cell lung cancer.
    Wang Y; Han X; Wang X; Sheng W; Chen Z; Shu W; Han J; Zhao S; Dai Y; Wang K; Shi W; Yang Z
    Jpn J Clin Oncol; 2019 Dec; 49(12):1143-1150. PubMed ID: 31612912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of the feasibility and prognostic value of circulating tumor DNA in detecting gene mutations in small cell lung cancer].
    Jin Y; Chen YM; Hu X; Tang HR; Yu XM; Fan Y; Xu YJ; Xu HM; Li PS; Li Q; Chang LP; Guan YF; Chen M
    Zhonghua Yi Xue Za Zhi; 2020 Dec; 100(45):3614-3621. PubMed ID: 33333686
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic impact of tumor mutation burden and the mutation in KIAA1211 in small cell lung cancer.
    Zhou M; Fan J; Li Z; Li P; Sun Y; Yang Y; Zhou X; Wang J; Wang Y; Qi H; Cai W; Dai X; Hirsch FR
    Respir Res; 2019 Nov; 20(1):248. PubMed ID: 31699089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational landscape of homologous recombination-related genes in small-cell lung cancer.
    Wu S; Zhang Y; Zhang Y; Chen LH; Ouyang HF; Xu X; Du Y; Ti XY
    Cancer Med; 2023 Feb; 12(4):4486-4495. PubMed ID: 36053931
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Wang L; Yan K; He X; Zhu H; Song J; Chen S; Cai S; Zhao Y; Wang L
    J Cancer; 2021; 12(1):217-223. PubMed ID: 33391418
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic profiling-based prognostic prediction of patients with advanced small-cell lung cancer in large scale analysis.
    Udagawa H; Umemura S; Murakami I; Mimaki S; Makinoshima H; Ishii G; Miyoshi T; Kirita K; Matsumoto S; Yoh K; Niho S; Tsuchihara K; Goto K
    Lung Cancer; 2018 Dec; 126():182-188. PubMed ID: 30527185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer.
    Xu F; Cui WQ; Liu C; Feng F; Liu R; Zhang J; Sun CG
    FEBS Open Bio; 2023 Jan; 13(1):72-88. PubMed ID: 36282125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Alteration and Their Significance on Clinical Events in Small Cell Lung Cancer.
    Jiao S; Zhang X; Wang D; Fu H; Xia Q
    Cancer Manag Res; 2022; 14():1493-1505. PubMed ID: 35469134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Profiling of Circulating Tumor DNA from Patients with Extensive-Stage Small Cell Lung Cancer Identifies Potentially Actionable Alterations.
    Yang J; Wang X; Lu J; Chen H; Zhao X; Gao C; Bai Y; Zhang Q; Fu X; Zhang X
    J Cancer; 2021; 12(17):5099-5105. PubMed ID: 34335926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Tumor Protein p53 and Ataxia-Telangiectasia Mutated Comutation With Response to Immune Checkpoint Inhibitors and Mortality in Patients With Non-Small Cell Lung Cancer.
    Chen Y; Chen G; Li J; Huang YY; Li Y; Lin J; Chen LZ; Lu JP; Wang YQ; Wang CX; Pan LK; Xia XF; Yi X; Chen CB; Zheng XW; Guo ZQ; Pan JJ
    JAMA Netw Open; 2019 Sep; 2(9):e1911895. PubMed ID: 31539077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic profiling of relapsed small cell lung cancer reveals potential pathways of therapeutic targets.
    Ouyang W; Yu J; Zeng Z; Gong J; Zhang J; Xie C
    J Thorac Dis; 2023 Dec; 15(12):6796-6805. PubMed ID: 38249912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic alterations and clinical outcomes in patients with lung adenocarcinoma with transformation to small cell lung cancer after treatment with EGFR tyrosine kinase inhibitors: A multicenter retrospective study.
    Wang W; Xu C; Chen H; Jia J; Wang L; Feng H; Wang H; Song Z; Yang N; Zhang Y
    Lung Cancer; 2021 May; 155():20-27. PubMed ID: 33714778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer.
    Ricciuti B; Kravets S; Dahlberg SE; Umeton R; Albayrak A; Subegdjo SJ; Johnson BE; Nishino M; Sholl LM; Awad MM
    J Immunother Cancer; 2019 Mar; 7(1):87. PubMed ID: 30922388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive genomic profiling of combined small cell lung cancer.
    Zhang J; Zhang L; Luo J; Ge T; Fan P; Sun L; Hou L; Li J; Yu H; Wu C; Zhu Y; Wu C; Jiang G; Troncone G; Malhotra J; Okuda K; Santarpia M; Zamarchi R; Goto T; Cardona AF; Xu J; Chen Q; Zhang Z; Zhang P;
    Transl Lung Cancer Res; 2021 Feb; 10(2):636-650. PubMed ID: 33718010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular gene mutation profiles, TMB and the impact of prognosis in Caucasians and east Asian patients with lung adenocarcinoma.
    Gu W; Wang N; Gu W; Qiu Y; Zhang H; Liang J; Zhou T; Ma L; Cai W; Feng W; Chen L
    Transl Lung Cancer Res; 2020 Jun; 9(3):629-638. PubMed ID: 32676325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.
    Rekhtman N; Pietanza MC; Hellmann MD; Naidoo J; Arora A; Won H; Halpenny DF; Wang H; Tian SK; Litvak AM; Paik PK; Drilon AE; Socci N; Poirier JT; Shen R; Berger MF; Moreira AL; Travis WD; Rudin CM; Ladanyi M
    Clin Cancer Res; 2016 Jul; 22(14):3618-29. PubMed ID: 26960398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KMT2D Mutation Is Associated With Poor Prognosis in Non-Small-Cell Lung Cancer.
    Ardeshir-Larijani F; Bhateja P; Lipka MB; Sharma N; Fu P; Dowlati A
    Clin Lung Cancer; 2018 Jul; 19(4):e489-e501. PubMed ID: 29627316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.